Selank nasal spray for anxiety and focus: what the science says

What did @fullonkaren actually say?

She dissolved selank powder in bacteriostatic water and administered it as a nasal spray, citing benefits for "depression, anxiety, hard to get tasks done, hard to focus." She sourced the peptide from a telehealth company, followed reconstitution instructions, and openly admitted she had "no personal experience yet" with this compound. She also floated the idea that "you can pretty much turn any peptide into a nose spray."

Credit where it's due: she was upfront about her lack of firsthand evidence, asked her audience for their experiences rather than presenting herself as an authority, and she followed a structured protocol from a named source rather than freelancing the dose. That's more epistemic humility than most biohacking content offers. The problem is in what she implied, not just what she said.

Does the science back this up?

Selank has legitimate research behind it, but almost none of it comes from Western peer-reviewed trials, and the nasal route specifically is understudied in rigorous human trials. The honest answer is: maybe, with real caveats.

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics in Russia. Most published human data comes from Russian-language trials conducted in the 1990s and 2000s, which evaluated intranasal delivery for generalized anxiety disorder. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reported anxiolytic effects in patients with anxiety-asthenic disorders using intranasal selank at doses of 400 mcg per day, with a favorable tolerability profile. A separate line of preclinical work, including studies by Uchakina et al. (2008, same journal), suggested selank modulates BDNF expression and influences serotonin and dopamine metabolism in animal models. That's interesting, not conclusive. No large-scale, placebo-controlled, FDA-reviewed trials exist for selank in any formulation. The nasal route does make pharmacological sense for peptides, since it bypasses first-pass metabolism and can allow CNS access via the olfactory pathway, but bioavailability data for selank specifically in nasal spray form is thin outside Russian literature.

What did they get wrong (or right)?

The claim that "you can pretty much turn any peptide into a nose spray" is wrong, and it's the most potentially dangerous thing said in the video. Peptide bioavailability via nasal mucosa depends on molecular weight, charge, enzymatic degradation in nasal secretions, and carrier formulation. Larger peptides, or those requiring specific pH or preservative conditions, won't absorb meaningfully this way, and some could cause local irritation or allergic response. This is not a universal method.

She also implies selank helps with depression, citing things she "read from different doctor creators." Selank has anxiolytic evidence; its antidepressant evidence in humans is far weaker. Conflating anxiety reduction with depression treatment is a meaningful clinical distinction that gets erased here.

What she got right: intranasal is actually the studied delivery route for selank specifically. Unlike some peptides where influencers invent nasal protocols, selank's Russian clinical data did use intranasal delivery. So for this particular compound, the route isn't invented. That's worth acknowledging.

What should you actually know?

Selank is not FDA-approved for any indication. It is not available as a regulated pharmaceutical in the United States. When sourced as a research peptide or through compounding channels, purity, sterility, and concentration cannot be assumed equal to pharmaceutical-grade products. This matters enormously when you're spraying something directly onto mucous membranes adjacent to your brain.

The anxiolytic signal from existing studies is real enough to warrant further research, but "real enough to warrant further research" and "safe and effective to self-administer based on TikTok" are not the same statement. If you're dealing with clinical depression or an anxiety disorder, a 30mg vial of a Russian-developed heptapeptide reconstituted at home is not a validated treatment path.

Anyone genuinely interested in selank should consult a licensed provider who can review their full medication list, because selank's interaction profile with SSRIs, benzodiazepines, or other CNS-active compounds is not well characterized in published literature.